Table 3
Open in new tab

Incidence of MACE

Number of patientsNumber of MACE (%)Annualized MACE rate (95% CI)
Overall4644340 (7.3)1.4 (1.3–1.6)
No CAD2579125 (4.9)0.9 (0.8–1.1)
Non-obstructive CAD2065215 (10.4)2.1 (1.8–2.4)
 Without proximal disease29822 (7.4)1.3 (0.9–2.0)
 With proximal disease1767193 (10.9)2.2 (1.9–2.5)
Number of patientsNumber of MACE (%)Annualized MACE rate (95% CI)
Overall4644340 (7.3)1.4 (1.3–1.6)
No CAD2579125 (4.9)0.9 (0.8–1.1)
Non-obstructive CAD2065215 (10.4)2.1 (1.8–2.4)
 Without proximal disease29822 (7.4)1.3 (0.9–2.0)
 With proximal disease1767193 (10.9)2.2 (1.9–2.5)

CAD, coronary artery disease; CI, confidence interval; MACE, major adverse cardiovascular events.

Table 3
Open in new tab

Incidence of MACE

Number of patientsNumber of MACE (%)Annualized MACE rate (95% CI)
Overall4644340 (7.3)1.4 (1.3–1.6)
No CAD2579125 (4.9)0.9 (0.8–1.1)
Non-obstructive CAD2065215 (10.4)2.1 (1.8–2.4)
 Without proximal disease29822 (7.4)1.3 (0.9–2.0)
 With proximal disease1767193 (10.9)2.2 (1.9–2.5)
Number of patientsNumber of MACE (%)Annualized MACE rate (95% CI)
Overall4644340 (7.3)1.4 (1.3–1.6)
No CAD2579125 (4.9)0.9 (0.8–1.1)
Non-obstructive CAD2065215 (10.4)2.1 (1.8–2.4)
 Without proximal disease29822 (7.4)1.3 (0.9–2.0)
 With proximal disease1767193 (10.9)2.2 (1.9–2.5)

CAD, coronary artery disease; CI, confidence interval; MACE, major adverse cardiovascular events.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close